| Carlitta Theresa Harris, | |
|
501 School Street Suite, Suite 200, Sw, DC 20016 | |
| (703) 752-8700 | |
| Not Available |
| Full Name | Carlitta Theresa Harris |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 501 School Street Suite, Sw, District Of Columbia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376191072 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 0024181043 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospice Of The Chesapeake, Inc. | 0244202463 | 11 |
News Archive
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
SensAble Technologies Inc., a leading provider of dental restoration design and fabrication solutions, 3D modeling software and haptic devices, announced that it has further expanded its network of European partners in service to the growing dental lab business in Europe. The company today announced partnerships with SILADENT Dr. Böhme & Schöps GmbH, Goslar, German and Innodema, an alliance of dental lab fabrication experts based in Belgium, both of whom become SensAble Authorized Production Centers (SAPCs).
A research team led by scientists at The University of Texas Medical School at Houston has identified a defective gene that affects vascular smooth-muscle cells in people who suffer from hereditary thoracic aortic disease, which can kill victims with little warning in the prime of their lives.
While the Western press often targets religious groups for their roles in handling the African AIDS crisis, these groups tend to play positive - and critical - roles in fighting the epidemic, according to sociologists.
› Verified 5 days ago
| Entity Name | Hospice Of The Chesapeake, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750575908 PECOS PAC ID: 0244202463 Enrollment ID: O20050721000905 |
News Archive
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
SensAble Technologies Inc., a leading provider of dental restoration design and fabrication solutions, 3D modeling software and haptic devices, announced that it has further expanded its network of European partners in service to the growing dental lab business in Europe. The company today announced partnerships with SILADENT Dr. Böhme & Schöps GmbH, Goslar, German and Innodema, an alliance of dental lab fabrication experts based in Belgium, both of whom become SensAble Authorized Production Centers (SAPCs).
A research team led by scientists at The University of Texas Medical School at Houston has identified a defective gene that affects vascular smooth-muscle cells in people who suffer from hereditary thoracic aortic disease, which can kill victims with little warning in the prime of their lives.
While the Western press often targets religious groups for their roles in handling the African AIDS crisis, these groups tend to play positive - and critical - roles in fighting the epidemic, according to sociologists.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carlitta Theresa Harris, 1309 Brookside Dr, Oxon Hill, MD 20745-3834 Ph: () - | Carlitta Theresa Harris, 501 School Street Suite, Suite 200, Sw, DC 20016 Ph: (703) 752-8700 |
News Archive
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
SensAble Technologies Inc., a leading provider of dental restoration design and fabrication solutions, 3D modeling software and haptic devices, announced that it has further expanded its network of European partners in service to the growing dental lab business in Europe. The company today announced partnerships with SILADENT Dr. Böhme & Schöps GmbH, Goslar, German and Innodema, an alliance of dental lab fabrication experts based in Belgium, both of whom become SensAble Authorized Production Centers (SAPCs).
A research team led by scientists at The University of Texas Medical School at Houston has identified a defective gene that affects vascular smooth-muscle cells in people who suffer from hereditary thoracic aortic disease, which can kill victims with little warning in the prime of their lives.
While the Western press often targets religious groups for their roles in handling the African AIDS crisis, these groups tend to play positive - and critical - roles in fighting the epidemic, according to sociologists.
› Verified 5 days ago